Previous 10 | Next 10 |
Agilent Technologies Inc. (NYSE: A), today announced that Dr. Katharine (Kate) Knobil is joining Agilent as the company’s chief medical officer (CMO). The chief medical officer at Agilent is a newly created position designed to advise, lead, and elevate the company’s prese...
Kit expands Agilent’s product portfolio aimed at COVID-19 detection Agilent Technologies Inc. (NYSE: A) today announced the launch of a real-time reverse transcription (qRT) PCR-based diagnostic kit for the detection of SARS-CoV-2 RNA. The CE-IVD mark is in accordance...
Whether a stock moves fast or slow, one thing is always true. The forces of supply and demand determine the price of Agilent Technologies (NYSE: A) and every other stock on the market. The price someone is willing to pay for A directly impacts its price, but that is offset b...
Agilent Technologies (A) has priced $850M of series of notes due March 2031.With annual interest rate of 2.3%, the offering is expected to close on March 12. The estimated net proceeds to be ~$841.1M, which will be used to redeem 3.20% senior notes due 2022 and for general corporate purposes....
Agilent Technologies, Inc. (NYSE: A) today announced the pricing of an underwritten, registered public offering of a series of its senior notes in an aggregate principal amount of $850 million. The offering is being conducted under an automatic shelf registration statement on file with ...
Agilent Technologies (A) offers automatic shelf registration for a series of senior notes with SEC.Actual terms of the notes, including interest rate, principal amount, and maturity, will depend on market conditions at the time of pricing.Company intends to use the net proceeds to fund t...
Cruise stock investors caught a break on Tuesday, when analysts at Australia's Macquarie Group upgraded stocks across the sector: And all three stocks are up in early afternoon trading, 3.5%, 3.2%, and 2.9%, respectively, as of 12:15 p.m. EST. Image source: Getty Images. C...
Highlights : Resolution Bioscience is a fast-growing, innovative leader in next-generation sequencing (NGS)-based oncology solutions. Combination brings together Resolution Bioscience’s noninvasive liquid biopsy platform that improves cancer diagnostics with Agilent...
Agilent Technologies (A) has agreed to acquire Washington-based developer of cancer tests, Resolution Bioscience, in an all-cash deal worth $550M.The deal which requires Agilent to pay an additional $145M if Resolution Bioscience achieves certain milestones is expected to close in April and w...
Award offers recognition and support for promising women scientists Agilent Technologies Inc. (NYSE: A) today announced that the recipient of the 2021 Darlene Solomon Award is Noemi Jiménez-Rojo, a postdoctoral fellow studying membrane biology, lipid diversity, and func...
News, Short Squeeze, Breakout and More Instantly...
Agilent Technologies Inc. Company Name:
A Stock Symbol:
NYSE Market:
Agilent Technologies Inc. Website:
Technology helps high-throughput labs operate more efficiently Agilent Technologies Inc. (NYSE: A) today announced it has acquired Sigsense Technologies , a San Francisco, California-based startup that uses artificial intelligence and power monitoring to help optimize lab operatio...
Expands Agilent’s end-to-end biopharma solutions that accelerate drug discovery, development, and manufacturing Agilent Technologies Inc. (NYSE: A) today announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturin...
2024-07-21 07:07:00 ET At long last, Europe has a space rocket, the Ariane 6, able to compete with SpaceX and its ubiquitous Falcon 9. The Ariane 6 isn't a reusable rocket, it arrived four years later than it was supposed to, and it probably costs about twice as much as a Falcon. But fo...